no more compounded semaglutide Troubling Findings in Study of GLP-1 Compounders Compounding pharmacies to halt semaglutide

These tend to appear during dose escalation and fade as the body adapts

NCHS Data Brief 2020;360:18

These include: Nausea Vomiting Diarrhoea Constipation Abdominal discomfort or bloating Reduced appetite (which may be intentional but can become excessive) These effects are typically most pronounced during the dose-escalation phase and tend to diminish as the body adjusts to the medication

Typically, patients start with a lower dosage to acclimate to the side effects, and during this initial period, significant weight loss should not be expected immediately

While still investigational and awaiting FDA approval, retatrutide shows that targeting multiple pathways at once can get close to surgical weight loss numbers, without surgery

The GLP-1 injection technique guide covers the step-by-step process including proper angle, pinch technique, and post-injection care